ICD-10 Code B78.1 | Cutaneous strongyloidiasis Symptoms, Diagnosis, Billing

Cutaneous strongyloidiasis is a parasitic infection caused by Strongyloides stercoralis, primarily affecting the skin. It is clinically significant due to its potential to cause severe dermatological manifestations and systemic complications. Accurate coding with ICD-10 Code B78.1 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this condition.

What is ICD-10 Code B78.1 for Cutaneous strongyloidiasis?

ICD-10 Code B78.1 represents Cutaneous strongyloidiasis, a skin manifestation of the Strongyloides stercoralis infection. This code should be used when documenting cases of skin lesions or rashes associated with this parasitic infection, ensuring accurate clinical documentation and appropriate billing for healthcare services rendered.

ICD-10 Code B78.1 – Clinical Definition and Explanation of Cutaneous strongyloidiasis

Cutaneous strongyloidiasis is caused by the penetration of Strongyloides stercoralis larvae through the skin, leading to localized inflammatory reactions. The condition can progress to more severe systemic infections if left untreated, necessitating prompt medical attention.

Key Clinical Features:

• Erythematous papules or plaques at the site of larval entry.
• Pruritus and discomfort associated with skin lesions.
• Potential for secondary bacterial infections due to scratching.
• History of exposure to contaminated soil or feces.

ICD-10 Code B78.1 for Cutaneous strongyloidiasis – SOAP Notes & Clinical Use

In SOAP notes, ICD-10 Code B78.1 is utilized to document the presence of cutaneous strongyloidiasis, aiding in the assessment of symptoms, clinical findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code B78.1 for Cutaneous strongyloidiasis Mean in SOAP Notes?

ICD-10 Code B78.1 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of cutaneous strongyloidiasis. This code is crucial for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code B78.1 – Cutaneous strongyloidiasis

Prompt treatment of cutaneous strongyloidiasis is essential to prevent complications and manage symptoms effectively.

Antibiotic Therapy:

• Ivermectin is the first-line treatment, typically administered as a single dose.
• Albendazole may be used as an alternative in certain cases.
• Treatment duration may vary based on clinical response and severity.

Supportive Care:

• Topical corticosteroids to reduce inflammation and itching.
• Antihistamines for symptomatic relief of pruritus.
• Proper wound care to prevent secondary infections.

Infection Control:

• Educate patients on avoiding exposure to contaminated soil.
• Implement hygiene measures to prevent spread in endemic areas.
• Monitor for signs of systemic infection in immunocompromised patients.

How to Document Symptoms of Cutaneous strongyloidiasis (ICD-10 B78.1) in SOAP Notes

Subjective:

• Patient reports itchy, red lesions on the lower extremities.
• History of travel to endemic areas with poor sanitation.
• Complaints of discomfort and difficulty sleeping due to itching.

Objective:

• Erythematous papules noted on physical examination.
• No signs of secondary infection observed.
• Vital signs stable; no fever present.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Cutaneous strongyloidiasis (ICD-10 Code B78.1)

Assessment:

• Diagnosis: Cutaneous strongyloidiasis, mild severity.
• ICD-10 Code: B78.1.
• Contributing factors: Recent travel to endemic region.

Plan:

• Initiate treatment with ivermectin as per guidelines.
• Educate patient on skin care and hygiene practices.
• Schedule follow-up in one week to assess treatment response.

Treatment & Plan Section for ICD-10 Code B78.1 – Cutaneous strongyloidiasis

• First-line treatment with ivermectin, single dose.
• Topical corticosteroids for symptomatic relief.
• Patient education on hygiene and prevention.
• Follow-up appointment to monitor treatment efficacy.

Using ICD-10 Code B78.1 for Cutaneous strongyloidiasis in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings.
• Use B78.1 for billing related to cutaneous manifestations.
• Align treatment plans with clinical guidelines for justified billing.
• Document any relevant comorbidities or complications.

Related ICD-10 Codes Often Used with Cutaneous strongyloidiasis

• B78.0 – Strongyloidiasis, unspecified
• B74.1 – Strongyloides stercoralis infection
• B35.3 – Tinea corporis

ICD-10 Code B78.1 in Medical Billing and Insurance for Cutaneous strongyloidiasis

ICD-10 Code B78.1 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document all relevant clinical findings to support the claim.
• Use B78.1 in conjunction with other codes for comprehensive billing.
• Ensure accurate coding to prevent claim denials.

Common CPT Pairings: